Palantir Price Target Jumps to $200 on Defense Demand; 2,130 Sites Integrated
Rosenblatt raised Palantir’s price target to $200 from $150 on a 1.2× PEG of 2027 EPS, citing geopolitical tensions, a U.S. phase-out of Anthropic AI models and heightened defense demand. OneMedNet has integrated over 2,130 healthcare sites into its iRWD platform powered by Palantir, driving subscription conversions and ARR growth.
1. Rosenblatt Raises Price Target to $200
Rosenblatt increased Palantir’s price target from $150 to $200, applying a 1.2× price-to-earnings-growth multiple to projected 2027 EPS. The upgrade reflects higher estimates for long-term performance compared to broader Wall Street forecasts and factors in megatrends in data analytics.
2. Geopolitical Shifts Fuel Defense Software Demand
Heightened global instability and recent directives phasing out Anthropic’s AI models have prompted defense agencies to seek integrated data platforms. Palantir’s solutions are positioned to replace standalone large language models, potentially consolidating contracts and expanding wartime data analysis deployments.
3. OneMedNet Integration Marks Platform Adoption
OneMedNet has brought over 2,130 healthcare sites onto its iRWD platform powered by Palantir, converting trials into commercial subscriptions. This network expansion is expected to drive predictable growth, boost deal sizes and contribute millions in incremental annual recurring revenue.